- You can view the full Agilent Ratings Report.
- Use our electronics section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
What's next for shares of Agilent Technology.
Agilent turned in another stellar earnings results.
Previously studies already showed improvement from use of Exelixis's Cabometyx over Pfizer's Sutent in treating kidney cancer patients.
U.S. stock futures are higher on Tuesday.